Search Back New search Go to resultsDiseaseMain groupSolid TumorsProtocol groupGastroenterologic OncologyGynecological OncologyThoracic TumorsTumor, regardless of entityDiseaseBreast CancerLung Carcinoma, Non-Small CellLung Carcinoma, Small CellTumor, Various OrgansSubgroupICD10C34.-C50.-MeSHBreast NeoplasmsSmall Cell Lung CarcinomaSequenceChemotherapyChemo-substanceCisplatinHydrocortisoneThiotepaChemo-substanceCisplatinHydrocortisoneThiotepaChemo-substanceCisplatinHydrocortisoneThiotepaChemo-substanceCisplatinHydrocortisoneThiotepaNo. Substances12 RadiotherapySupportive therapySupportive substanceSupportive substanceSupportive substanceSupportive substanceNo. SubstancesProtocol classificationTherapy classificationalternativeIntensityStandard doseTherapy indicationseveral possibleTherapy phaseTherapy intentionpalliativeRisksCardiotoxicityEmetogenicity only studiesPublicationAuthorMaisch BMartinoni A DiseaseMaligner Perikarderguss, hämodynamisch relevantOriginCardiology Unit, Milan, ItalyDepartment of Internal Medicine-Cardiology, Philipps University, Marburg, GermanyProtocols in Revision 2 protocols foundProtocols under revision.Cisplatin 30, Tumor, Various Organs (PID2371 V1.0)Thiotepa 15 / Hydrocortisone 30, Tumor, Various Organs (PID2372 V1.0)
